Characteristic | Study group (PCEA) | Control group (IV-PCA) | p-value |
---|---|---|---|
Number of participants | 110 | 90 | - |
Age (years) | 60.89 ± 2.67 | 60.84 ± 2.46 | 0.89 |
Gender (male/female) | 56/54 | 49/41 | 0.65 |
Weight (kg) | 58.5 ± 8.7 | 59.2 ± 7.9 | 0.72 |
Body mass index (BMI, kg/m2) | 22.8 ± 1.5 | 22.7 ± 1.6 | 0.81 |
Duration of osteoarthritis (years) | 6.8 ± 2.3 | 6.5 ± 2.1 | 0.68 |
ASA class I/II (% participants) | 65% / 35% | 68% / 32% | 0.57 |
Smoking status (% smokers) | 28% | 30% | 0.78 |
Comorbidities | |||
Hypertension | 25% | 27% | 0.76 |
Diabetes mellitus | 18% | 20% | 0.68 |
Coronary artery disease | 12% | 11% | 0.89 |
Preoperative haemoglobin (g/dL) | 13.6 ± 0.8 | 13.4 ± 0.9 | 0.43 |
Preoperative pain level (VAS) | 6.8 ± 1.2 | 6.7 ± 1.1 | 0.85 |
Duration of symptoms (months) | 72 ± 18 | 70 ± 16 | 0.74 |
Preoperative mobility | |||
Able to walk independently (%) | 60% | 62% | 0.71 |
Requires walking aid (%) | 40% | 38% | 0.72 |
Preoperative sedation score (RSS) | 1.9 ± 0.5 | 2.0 ± 0.4 | 0.81 |